News Chan Zuckerberg Initiative to put $250M into new NYC Biohub The Chan Zuckerberg Initiative's new NYC Biohub will develop new bio-engineered immune cells that can aide in early detection of diseases.
Patients Empowering rare disease patient advocacy organisations with ... Komodo Health’s president and co-founder, Web Sun, tells us about his company’s new partnership with the Chan Zuckerberg Initiative (CZI) to improve early diagnosis and advance research of
Oncology Treating primary bone cancer: The potential of listeria-base... In a new pharmaphorum podcast, Paul Romness, president and CEO of OS Therapies, discusses the company's work in osteosarcoma.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face